Geode Capital Management’s IN8bio INAB Stock Holding History
Bought
Maintained
Sold
Other funds holding INAB
6CM
SCM
BCM
OC
Geode Capital Management's INAB Position: Q2 2026 in Review
Geode Capital Management reduced its IN8bio (INAB) stake by 16% in Q2 2026, selling an estimated $20.6K and leaving 72,550 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #4095.
Geode Capital Management first reported a position in INAB in Q3 2022 and has held it in 16 quarters since. The position peaked at $331K in Q1 2024. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.
- Geode Capital Management held 72,550 shares of IN8bio worth $102K as of Q2 2026.
- Geode Capital Management sold 13,689 IN8bio shares in Q2 2026, an estimated $20.6K.
- IN8bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4095 holding.
- Geode Capital Management first reported a position in IN8bio in Q3 2022 and has held it in 16 quarters since.
- Geode Capital Management's IN8bio position peaked at $331K in Q1 2024.
- 21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.